• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双时相 F-氟比洛芬 PET 提供阿尔茨海默病的脑灌注代理以及β淀粉样蛋白负担。

Dual-phase F-florbetaben PET provides cerebral perfusion proxy along with beta-amyloid burden in Alzheimer's disease.

机构信息

Department of Nuclear Medicine, Ewha Womans University, School of Medicine, Seoul, Republic of Korea.

Department of Nuclear Medicine, Ewha Womans University, School of Medicine, Seoul, Republic of Korea.

出版信息

Neuroimage Clin. 2021;31:102773. doi: 10.1016/j.nicl.2021.102773. Epub 2021 Jul 24.

DOI:10.1016/j.nicl.2021.102773
PMID:34339946
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8346681/
Abstract

BACKGROUND

This study investigated changes in brain perfusion and Aβ burden according to the progression of Alzheimer's disease (AD) by using a dual-phase F-florbetaben (FBB) PET protocol.

METHODS

Sixty subjects, including 12 with Aβ-negative normal cognition (AβNC), 32 with Aβ-positive mild cognitive impairment (AβMCI), and 16 with Aβ-positive AD (AβAD), were enrolled. A dynamic PET scan was obtained in the early phase (0-10 min, eFBB) and delayed phase (90-110 min, dFBB), which were then averaged into a single frame, respectively. In addition to the averaged eFBB, an R1 parametric map was calculated from the eFBB scan based on a simplified reference tissue model (SRTM). Between-group regional and voxel-wise analyses of the images were performed. The associations between cognitive profiles and PET-derived parameters were investigated.

RESULTS

Both the R1 and eFBB perfusion reductions in the cortical regions were not significantly different between the AβNC and AβMCI groups, while they were significantly reduced from the AβMCI to AβAD groups in regional and voxel-wise analyses. However, cortical Aβ depositions on dFBB were not significantly different between the AβMCI and AβAD groups. There were strong positive correlations between the R1 and eFBB images in regional and voxel-wise analyses. Both perfusion components showed significant correlations with general and specific cognitive profiles.

CONCLUSION

The results of this study demonstrated the feasibility of dual-phase F-FBB PET to evaluate different trajectories of dual biomarkers for neurodegeneration and Aβ burden over the course of AD. In addition, both eFBB and SRTM-based R1 can provide robust indices of brain perfusion.

摘要

背景

本研究通过使用双期 F-氟比洛芬(FBB)PET 方案,研究了阿尔茨海默病(AD)进展过程中脑灌注和 Aβ 负担的变化。

方法

纳入 60 名受试者,包括 12 名 Aβ 阴性正常认知(AβNC)、32 名 Aβ 阳性轻度认知障碍(AβMCI)和 16 名 Aβ 阳性 AD(AβAD)。获得了早期相(0-10 分钟,eFBB)和延迟相(90-110 分钟,dFBB)的动态 PET 扫描,然后分别将其平均为单个帧。除了平均 eFBB 外,还根据简化参考组织模型(SRTM)从 eFBB 扫描中计算了 R1 参数图。对图像进行了组间区域和体素分析。研究了认知特征与 PET 衍生参数之间的相关性。

结果

皮质区域的 R1 和 eFBB 灌注减少在 AβNC 和 AβMCI 组之间没有显著差异,而在区域和体素分析中,从 AβMCI 到 AβAD 组显著减少。然而,在 AβMCI 和 AβAD 组之间,dFBB 上的皮质 Aβ 沉积没有显著差异。在区域和体素分析中,R1 和 eFBB 图像之间存在强烈的正相关。两种灌注成分均与一般和特定认知特征显著相关。

结论

本研究结果表明,双期 F-FBB PET 用于评估 AD 过程中神经退行性变和 Aβ 负担的双生物标志物的不同轨迹是可行的。此外,eFBB 和基于 SRTM 的 R1 都可以提供大脑灌注的可靠指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c70b/8346681/c3fec7bb7e58/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c70b/8346681/c5eef80a9986/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c70b/8346681/2debd6c2bee9/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c70b/8346681/7a20daf78f14/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c70b/8346681/9d3e13eb0c87/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c70b/8346681/d3dedf4095e2/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c70b/8346681/4a49f3eaa98f/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c70b/8346681/37ac28c4b8db/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c70b/8346681/c3fec7bb7e58/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c70b/8346681/c5eef80a9986/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c70b/8346681/2debd6c2bee9/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c70b/8346681/7a20daf78f14/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c70b/8346681/9d3e13eb0c87/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c70b/8346681/d3dedf4095e2/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c70b/8346681/4a49f3eaa98f/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c70b/8346681/37ac28c4b8db/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c70b/8346681/c3fec7bb7e58/gr8.jpg

相似文献

1
Dual-phase F-florbetaben PET provides cerebral perfusion proxy along with beta-amyloid burden in Alzheimer's disease.双时相 F-氟比洛芬 PET 提供阿尔茨海默病的脑灌注代理以及β淀粉样蛋白负担。
Neuroimage Clin. 2021;31:102773. doi: 10.1016/j.nicl.2021.102773. Epub 2021 Jul 24.
2
Elevated cerebral blood flow proxy with increased beta-amyloid burden in Alzheimer's disease preclinical phase evaluated by dual-phase F-florbetaben positron emission tomography.双时相 F-氟脱氧葡萄糖正电子发射断层扫描评估阿尔茨海默病临床前期β淀粉样蛋白负荷增加的脑血流升高标志物。
Sci Rep. 2024 Aug 9;14(1):18480. doi: 10.1038/s41598-024-68916-4.
3
Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment.双相(18)F-氟代硼吡咯(AV-45/Amyvid)PET在阿尔茨海默病和轻度认知障碍中同时检测灌注缺损和β-淀粉样蛋白沉积的成像特征
Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1304-14. doi: 10.1007/s00259-016-3359-8. Epub 2016 Mar 22.
4
Dual Time-Point [18F]Florbetaben PET Delivers Dual Biomarker Information in Mild Cognitive Impairment and Alzheimer's Disease.双时间点 [18F]氟比洛芬乙酯 PET 提供轻度认知障碍和阿尔茨海默病的双重生物标志物信息。
J Alzheimers Dis. 2018;66(3):1105-1116. doi: 10.3233/JAD-180522.
5
Early [(18)F]florbetaben and [(11)C]PiB PET images are a surrogate biomarker of neuronal injury in Alzheimer's disease.早期的[(18)F]氟代贝他班和[(11)C]匹兹堡复合物B正电子发射断层扫描(PET)图像是阿尔茨海默病中神经元损伤的替代生物标志物。
Eur J Nucl Med Mol Imaging. 2016 Aug;43(9):1700-9. doi: 10.1007/s00259-016-3353-1. Epub 2016 Mar 30.
6
The Precuneus - A Witness for Excessive Aβ Gathering in Alzheimer's Disease Pathology.楔前叶 - 在阿尔茨海默病病理中过度 Aβ 聚集的见证者。
Neurodegener Dis. 2018;18(5-6):302-309. doi: 10.1159/000492945. Epub 2019 Feb 27.
7
Aβ imaging with 18F-florbetaben in prodromal Alzheimer's disease: a prospective outcome study.使用 18F-氟比他滨对前驱期阿尔茨海默病进行 Aβ 成像:一项前瞻性结局研究。
J Neurol Neurosurg Psychiatry. 2015 Apr;86(4):431-6. doi: 10.1136/jnnp-2014-308094. Epub 2014 Jun 26.
8
Early-phase amyloid PET reproduces metabolic signatures of cognitive decline in Parkinson's disease.早期淀粉样蛋白PET重现帕金森病认知衰退的代谢特征。
Alzheimers Dement (Amst). 2024 Jun 22;16(2):e12601. doi: 10.1002/dad2.12601. eCollection 2024 Apr-Jun.
9
Early-Frame [F]Florbetaben PET/MRI for Cerebral Blood Flow Quantification in Patients with Cognitive Impairment: Comparison to an [O]Water Gold Standard.早期帧[F]氟比洛芬 PET/MRI 脑血流定量在认知障碍患者:与[O]水金标准比较。
J Nucl Med. 2024 Feb 1;65(2):306-312. doi: 10.2967/jnumed.123.266273.
10
Evaluation of early-phase [F]-florbetaben PET acquisition in clinical routine cases.临床常规病例中早期[F] - 氟代苯并噻唑啉正电子发射断层扫描(PET)采集的评估
Neuroimage Clin. 2016 Oct 8;14:77-86. doi: 10.1016/j.nicl.2016.10.005. eCollection 2017.

引用本文的文献

1
Potential utility of salivary gland amyloid uptake as a surrogate marker for adipose tissue and amyloid-beta dynamics based on its association with BMI and cerebral amyloid burden.基于唾液腺淀粉样蛋白摄取与体重指数及脑淀粉样蛋白负荷的关联,其作为脂肪组织和β淀粉样蛋白动态变化替代标志物的潜在效用。
Sci Rep. 2025 Jul 15;15(1):25513. doi: 10.1038/s41598-025-11731-2.
2
Machine learning model for predicting Amyloid-β positivity and cognitive status using early-phase F-Florbetaben PET and clinical features.使用早期¹⁸F-氟贝他班PET和临床特征预测β淀粉样蛋白阳性和认知状态的机器学习模型
Sci Rep. 2025 Jul 1;15(1):21987. doi: 10.1038/s41598-025-00743-7.
3
Correlation of early-phase β-amyloid positron-emission-tomography and neuropsychological testing in patients with Alzheimer's disease.
阿尔茨海默病患者早期β-淀粉样蛋白正电子发射断层扫描与神经心理学测试的相关性
Eur J Nucl Med Mol Imaging. 2025 Feb 28. doi: 10.1007/s00259-025-07175-5.
4
Impact of shortening time on diagnosis of F-florbetaben PET.缩短时间对F-氟代硼替佐米正电子发射断层扫描(PET)诊断的影响。
EJNMMI Res. 2024 Nov 21;14(1):114. doi: 10.1186/s13550-024-01181-8.
5
Comparative Diagnostic Performance of Amyloid-β Positron Emission Tomography and Magnetic Resonance Imaging in Alzheimer's Disease: A Head-to-Head Meta-Analysis.阿尔茨海默病中淀粉样蛋白-β正电子发射断层扫描和磁共振成像的比较诊断性能:一项头对头的荟萃分析。
Brain Behav. 2024 Oct;14(10):e70111. doi: 10.1002/brb3.70111.
6
Elevated cerebral blood flow proxy with increased beta-amyloid burden in Alzheimer's disease preclinical phase evaluated by dual-phase F-florbetaben positron emission tomography.双时相 F-氟脱氧葡萄糖正电子发射断层扫描评估阿尔茨海默病临床前期β淀粉样蛋白负荷增加的脑血流升高标志物。
Sci Rep. 2024 Aug 9;14(1):18480. doi: 10.1038/s41598-024-68916-4.
7
Amyloid PET Imaging: Standard Procedures and Semiquantification.淀粉样蛋白 PET 成像:标准程序和半定量分析。
Methods Mol Biol. 2024;2785:165-175. doi: 10.1007/978-1-0716-3774-6_11.
8
Kinetic analysis of cardiac dynamic F-Florbetapir PET in healthy volunteers and amyloidosis patients: A pilot study.健康志愿者和淀粉样变性患者心脏动态F-氟代硼替吡PET的动力学分析:一项初步研究。
Heliyon. 2024 Feb 10;10(4):e26021. doi: 10.1016/j.heliyon.2024.e26021. eCollection 2024 Feb 29.
9
Early-Frame [F]Florbetaben PET/MRI for Cerebral Blood Flow Quantification in Patients with Cognitive Impairment: Comparison to an [O]Water Gold Standard.早期帧[F]氟比洛芬 PET/MRI 脑血流定量在认知障碍患者:与[O]水金标准比较。
J Nucl Med. 2024 Feb 1;65(2):306-312. doi: 10.2967/jnumed.123.266273.
10
The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partners Scientific Board (PPSB).阿尔茨海默病神经影像学倡议及私人合作伙伴科学理事会的作用和贡献。
Alzheimers Dement. 2024 Jan;20(1):695-708. doi: 10.1002/alz.13483. Epub 2023 Sep 29.